| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Molecular Genetics and Microbiology and
New York State Department of Health, State University of New York, Stony Brook, NY 11794
mAb CB2, directed against outer surface protein B (OspB), causes bacteriolysis of Borrelia burgdorferi in the absence of complement. How this happens is unknown. We examined the effect of mAb binding on OspB tertiary structure by using limited proteolysis to probe changes in protein conformation. Truncated OspB (tOspB) that lacked N-terminal lipid was cleaved by four enzymes: trypsin, endoproteinase Arg-C, endoproteinase Asp-N, and endoproteinase Glu-C. CB2 affected the cleavage by trypsin and Arg-C, but not by AspN or Glu-C. None of the enzymes cleaved CB2 under these conditions. Both trypsin and Arg-C cleaved tOspB near the N-terminus; CB2 slowed the rate of cleavage, but did not affect the identity of the sites cleaved. Irrelevant mAb had no effect, indicating that the effect was specific. CB2 was active against tOspB of strain B31, but not against tOspB of strain BEP4, to which it does not bind, suggesting that binding was required to elicit the effect on cleavage. With trypsin, CB2 showed a maximal effect at 8 mol of tOspB to 1 mol of mAb. At this ratio, not enough CB2 was present to bind all the tOspB; therefore, either CB2 shows turnover or CB2 acts by binding tOspB and effecting a change in this tOspB such that it, in turn, propagates the effect in other molecules of tOspB. Regardless of the mechanism, these data show that CB2 elicits a change in tOspB that can be measured by its reduced susceptibility to protease cleavage.
This article has been cited by other articles:
|
|
 |
|
  T. J. LaRocca, D. J. Holthausen, C. Hsieh, C. Renken, C. A. Mannella, and J. L. Benach The bactericidal effect of a complement-independent antibody is osmolytic and specific to Borrelia PNAS, June 30, 2009; 106(26): 10752 - 10757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Malkiel, C. J. Kuhlow, P. Mena, and J. L. Benach The Loss and Gain of Marginal Zone and Peritoneal B Cells Is Different in Response to Relapsing Fever and Lyme Disease Borrelia J. Immunol., January 1, 2009; 182(1): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. LaRocca, L. I. Katona, D. G. Thanassi, and J. L. Benach Bactericidal Action of a Complement-Independent Antibody against Relapsing Fever Borrelia Resides in Its Variable Region J. Immunol., May 1, 2008; 180(9): 6222 - 6228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Becker, J. Bunikis, B. D. Lade, J. J. Dunn, A. G. Barbour, and C. L. Lawson Structural Investigation of Borrelia burgdorferi OspB, a BactericidalFab Target J. Biol. Chem., April 29, 2005; 280(17): 17363 - 17370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Oli, N. Rhodin, W. P. McArthur, and L. J. Brady Redirecting the Humoral Immune Response against Streptococcus mutans Antigen P1 with Monoclonal Antibodies Infect. Immun., December 1, 2004; 72(12): 6951 - 6960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. T. Liang, J. Yan, M. L. Mbow, S. L. Sviat, R. D. Gilmore, M. Mamula, and E. Fikrig Borrelia burgdorferi Changes Its Surface Antigenic Expression in Response to Host Immune Responses Infect. Immun., October 1, 2004; 72(10): 5759 - 5767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Rhodin, J. M. Cutalo, K. B. Tomer, W. P. McArthur, and L. J. Brady Characterization of the Streptococcus mutans P1 Epitope Recognized by Immunomodulatory Monoclonal Antibody 6-11A Infect. Immun., August 1, 2004; 72(8): 4680 - 4688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Anderton, R. Tokarz, C. D. Thill, C. J. Kuhlow, C. S. Brooks, D. R. Akins, L. I. Katona, and J. L. Benach Whole-Genome DNA Array Analysis of the Response of Borrelia burgdorferi to a Bactericidal Monoclonal Antibody Infect. Immun., April 1, 2004; 72(4): 2035 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fikrig, U. Pal, M. Chen, J. F. Anderson, and R. A. Flavell OspB Antibody Prevents Borrelia burgdorferi Colonization of Ixodes scapularis Infect. Immun., March 1, 2004; 72(3): 1755 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Connolly, D. G. Thanassi, and J. L. Benach Generation of a Complement-Independent Bactericidal IgM against a Relapsing Fever Borrelia J. Immunol., January 15, 2004; 172(2): 1191 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Rhodin, M. L. J. A. Van Tilburg, M. W. Oli, W. P. McArthur, and L. J. Brady Further Characterization of Immunomodulation by a Monoclonal Antibody against Streptococcus mutans Antigen P1 Infect. Immun., January 1, 2004; 72(1): 13 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Lawrenz, R. M. Wooten, J. F. Zachary, S. M. Drouin, J. J. Weis, R. A. Wetsel, and S. J. Norris Effect of Complement Component C3 Deficiency on Experimental Lyme Borreliosis in Mice Infect. Immun., August 1, 2003; 71(8): 4432 - 4440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Jobe, S. D. Lovrich, R. F. Schell, and S. M. Callister C-Terminal Region of Outer Surface Protein C Binds Borreliacidal Antibodies in Sera from Patients with Lyme Disease Clin. Vaccine Immunol., July 1, 2003; 10(4): 573 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Connolly and J. L. Benach Cutting Edge: The Spirochetemia of Murine Relapsing Fever Is Cleared by Complement-Independent Bactericidal Antibodies J. Immunol., September 15, 2001; 167(6): 3029 - 3032. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
